BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 24252606)

  • 21. Desmopressin response in nocturnal enuresis showing concentrated urine.
    Akagawa S; Tsuji S; Akagawa Y; Yamanouchi S; Kimata T; Kaneko K
    Pediatr Int; 2020 Jun; 62(6):701-704. PubMed ID: 32065484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Desmopressin versus behavioral modifications as initial treatment of primary nocturnal enuresis.
    Fera P; Lelis MA; Glashan Rde Q; Pereira SG; Bruschini H
    Urol Nurs; 2011; 31(5):286-9. PubMed ID: 22073899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary monosymptomatic nocturnal enuresis and associated factors in a referral continence clinic of Abu Dhabi.
    Arena S; Patricolo M
    Pediatr Med Chir; 2017 Jun; 39(2):150. PubMed ID: 28673073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does smoking exposure affect response to treatment in children with primary monosymptomatic nocturnal enuresis?
    Kaya Aksoy G; Semerci Koyun N; Doğan ÇS
    J Pediatr Urol; 2020 Feb; 16(1):47.e1-47.e6. PubMed ID: 31735520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alarm interventions for nocturnal enuresis in children.
    Glazener CM; Evans JH; Peto RE
    Cochrane Database Syst Rev; 2005 Apr; (2):CD002911. PubMed ID: 15846643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined laser acupuncture and desmopressin for treating resistant cases of monosymptomatic nocturnal enuresis: a randomized comparative study.
    Moursy EE; Kamel NF; Kaseem AF
    Scand J Urol; 2014 Dec; 48(6):559-64. PubMed ID: 24909996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of treatment-resistant nocturnal enuresis.
    Tsuji S; Kaneko K
    Pediatr Int; 2023; 65(1):e15573. PubMed ID: 37428825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The efficacy of the addition of short-term desmopressin to alarm therapy in the treatment of primary nocturnal enuresis.
    Ozden C; Ozdal OL; Aktas BK; Ozelci A; Altinova S; Memis A
    Int Urol Nephrol; 2008; 40(3):583-6. PubMed ID: 18320340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Constipation in nocturnal enuresis may interfere desmopressin management success.
    Ma Y; Shen Y; Liu X
    J Pediatr Urol; 2019 Apr; 15(2):177.e1-177.e6. PubMed ID: 30594475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive parameters of response to desmopressin in primary nocturnal enuresis.
    Van Herzeele C; Evans J; Eggert P; Lottmann H; Norgaard JP; Vande Walle J
    J Pediatr Urol; 2015 Aug; 11(4):200.e1-8. PubMed ID: 26059526
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased renal concentrating ability after long-term oral desmopressin lyophilisate treatment contributes to continued success for monosymptomatic nocturnal enuresis.
    Ikeda H; Watanabe T; Isoyama K
    Int J Urol; 2017 Sep; 24(9):698-702. PubMed ID: 28636262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Desmopressin response in nocturnal enuresis without nocturnal polyuria in Japanese children.
    Akagawa S; Tsuji S; Akagawa Y; Yamanouchi S; Kimata T; Kaneko K
    Int J Urol; 2021 Sep; 28(9):964-968. PubMed ID: 34169597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is second-line enuretic alarm therapy after unsuccessful pharmacotherapy superior to first-line therapy in the treatment of monosymptomatic nocturnal enuresis?
    Tuygun C; Eroglu M; Bakirtas H; Gucuk A; Zengin K; Imamoglu A
    Urol Int; 2007; 78(3):260-3. PubMed ID: 17406138
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of desmopressin combined with alarm therapy for monosymptomatic nocturnal enuresis.
    Leebeek-Groenewegen A; Blom J; Sukhai R; Van Der Heijden B
    J Urol; 2001 Dec; 166(6):2456-8. PubMed ID: 11696811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Focus on desmopressin and enuresis: a review of literature.
    Ferrara P; Vena F; Basile MC; Ianniello F; Gatto A
    Minerva Urol Nefrol; 2016 Feb; 68(1):14-9. PubMed ID: 24990391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of desmopressin on renal water and solute handling in desmopressin resistant monosymptomatic nocturnal enuresis.
    Kamperis K; Rittig S; Radvanska E; Jørgensen KA; Djurhuus JC
    J Urol; 2008 Aug; 180(2):707-13; discussion 713-4. PubMed ID: 18554642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Poor compliance with primary nocturnal enuresis therapy may contribute to insufficient desmopressin response.
    Van Herzeele C; Alova I; Evans J; Eggert P; Lottmann H; Nørgaard JP; Vande Walle J
    J Urol; 2009 Oct; 182(4 Suppl):2045-9. PubMed ID: 19695639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimizing response to desmopressin in patients with monosymptomatic nocturnal enuresis.
    Kamperis K; Van Herzeele C; Rittig S; Vande Walle J
    Pediatr Nephrol; 2017 Feb; 32(2):217-226. PubMed ID: 27071997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Desmopressin and oxybutynin in monosymptomatic nocturnal enuresis: a randomized, double-blind, placebo-controlled trial and an assessment of predictive factors.
    Montaldo P; Tafuro L; Rea M; Narciso V; Iossa AC; Del Gado R
    BJU Int; 2012 Oct; 110(8 Pt B):E381-6. PubMed ID: 22313792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The treatment of primary nocturnal enuresis in Malaysia.
    Kanaheswari Y
    Med J Malaysia; 2006 Dec; 61(5):608-15. PubMed ID: 17623963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.